National Bank of Canada’s Prime Medicine PRME Stock Holding History

National Bank of Canada’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35	Buy	+10	New	+$38	﹤0.01%	2880
2025 Q4	–	Sell	-4,500	Closed	-$24.9K	–	3080
2025 Q3	$24.9K	Sell	4,500 -94,307	-95%	-$383K	﹤0.01%	2106
2025 Q2	$244K	Buy	+98,807	New	+$152K	﹤0.01%	1561
2025 Q1	–	Sell	-400	Closed	-$1.17K	–	3095
2024 Q4	$1.17K	Sell	400 -4,122	-91%	-$14.5K	﹤0.01%	2634
2024 Q3	$17.5K	Sell	4,522 -1,678	-27%	-$7.77K	﹤0.01%	1972
2024 Q2	$33.9K	Buy	+6,200	New	+$37.6K	﹤0.01%	1810

Other funds holding PRME

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

National Bank of Canada's PRME Position: Q1 2026 in Review

National Bank of Canada opened a new position in Prime Medicine (PRME) in Q1 2026: 10 shares worth $35. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in PRME as recently as Q3 2025.

National Bank of Canada first reported a position in PRME in Q2 2024 and has held it in 6 quarters since. The position peaked at $244K in Q2 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

National Bank of Canada held 10 shares of Prime Medicine worth $35 as of Q1 2026.
Prime Medicine was a new National Bank of Canada position in Q1 2026.
Prime Medicine made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2880 holding.
National Bank of Canada first reported a position in Prime Medicine in Q2 2024 and has held it in 6 quarters since.
National Bank of Canada's Prime Medicine position peaked at $244K in Q2 2025.
192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.